Curaleaf Holdings Files 6-K, Will Use Form 40-F

Ticker: CURLF · Form: 6-K · Filed: 2024-08-06T00:00:00.000Z

Sentiment: neutral

Topics: reporting, compliance, annual-report

TL;DR

Curaleaf filed a 6-K, confirming they'll use Form 40-F for their annual report.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on August 6, 2024, indicating it will file its annual report under Form 40-F. The filing includes a press release as Exhibit 99.1. Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc.

Why It Matters

This filing signals Curaleaf's compliance with reporting requirements and its chosen method for annual reporting, which is standard for Canadian companies reporting to the SEC.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming reporting status and not disclosing new material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is filed to indicate that Curaleaf Holdings, Inc. will file its annual report under cover of Form 40-F and to provide a press release as an exhibit.

Which form will Curaleaf Holdings, Inc. use for its annual report?

Curaleaf Holdings, Inc. will use Form 40-F for its annual report.

Who signed the Form 6-K on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the Form 6-K.

What is the filing date of this report?

The filing date of this report is August 6, 2024.

What is the principal executive office address listed for Curaleaf Holdings, Inc.?

The address of the Principal Executive Office is 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

From the Filing

0001756770-24-000051.txt : 20240806 0001756770-24-000051.hdr.sgml : 20240806 20240806131812 ACCESSION NUMBER: 0001756770-24-000051 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240806 FILED AS OF DATE: 20240806 DATE AS OF CHANGE: 20240806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 241178280 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover080624.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: August 6, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated August 5 , 2024 EX-99.1 2 pressrelease080624.htm EX-99.1 Document Curaleaf to Begin Adult-Use Sales in Ohio on August 6 Curaleaf Products will be Available to Adults 21 and Over at Licensed Dispensaries Across Ohio Curaleaf Newark to Commence Adult-Use Sales on August 6, 2024 STAMFORD, CT, August 5, 2024 – Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF)s ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced it will commence adult-use operations in Ohio. Beginning August 6, 2024, Curaleaf Newark will open for both adult-use and medical patients. Additionally on August 6, adults over the age of 21 will be able to purchase the Company’s premium cannabis products from third-party state-licensed dispensaries across the state. Across the state, Curaleaf invites adult-use consumers to explore its wide array of premium products, including Select Briq, Select X Bites, Curaleaf and Grassroots flower, JAMS Jellies, and Plant Precision Ratio Bites. Curaleaf will welcome both medical patients and adult-use customers at Curaleaf Newark, located at 1150 North 21st Street, Newark, OH 43055. Dedicated dispensary associates will be on hand to answer questions, provide guidance, and help customers embark on their next cannabis adventure with safe, reliable, and effective cannabis products. Curaleaf Cuyahoga Falls is currently open to medical patients and will open to adult-use customers at a later date, pending regulatory approval. “We have been eagerly anticipating the opportunity to serve a new community of Ohioians, and are thrilled to be a part of the first group of operators to kick off adult-use sales in the state,” said Matt Darin, CEO of Curaleaf. “We firmly believe that Ohio has the potential to be one of the nation’s most exciting cannabis markets and have prepared for this moment by increasing cultivation capacity and prioritizing flower availabili

View on Read The Filing